MLANA (8G7) Monoclonal Antibody

Flow cytometric analysis of B16-F1 cells with MelanA (8G7) Monoclonal Antibody (bsm-52517R) at 1:50 dilution followed by secondary antibody incubation (red), compared with an unlabeled control (cells without incubation with primary antibody; black).

$Lane 1: Melanoma Cells; Lane 2: B16-F1 Cells; Probed with MelanA (8G7) Monoclonal Antibody (bsm-52517R) at 1:1000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Melanoma Cells; Lane 2: B16-F1 Cells; Probed with MelanA (8G7) Monoclonal Antibody (bsm-52517R) at 1:1000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

Applications

Reactivity

Human
Mouse

Overview
Catalog #	bsm-52517R
Product Name	MLANA (8G7) Monoclonal Antibody
Applications	WB, FCM
Reactivity	Human, Mouse
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Human MLANA between 1-100 amino acids
Clonality	Monoclonal
Clone #	#REF!
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Store at -20C for 12 months.
Target
Gene ID	2315
Swiss Prot	Q16655
Synonyms	Melanoma antigen recognized by T-cells 1, Antigen LB39-AA, Antigen SK29-AA, Protein Melan-A, MLANA
Background	Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.
Application Dilution
WB	1:300-5000
FCM	1:20-100